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ABSTRACT 
 
BACKGROUND – There are known risk factors associated with the development of heart failure (HF), but it is 
not fully understood whether these differ by sex.  
OBJECTIVES - To investigate sex differences in risk factors for HF incidence and mortality.  
METHODS – 468 941 participants (55.9% women, age range 37 to 73 years) were included. Established CVD 
risk factors (hypertension, hypercholesterolemia, diabetes type 1 and 2, adiposity, smoking, physical activity and 
poor diet) and novel risk factors (grip strength, fitness, TV-viewing and sleep duration) were the exposures of 
interest. HF incidence and mortality were the outcomes.  
RESULTS – Over a mean follow-up of 9.0 years, 1812 participants developed HF and 763 died due to HF. 
Women with type 1 diabetes (T1DM), type 2 diabetes (T2DM), hypertension, hypercholesterolemia, low levels 
of physical activity and fitness, low strength, high levels of TV-viewing, sleep duration <7 h/day, smokers, those 
who were underweight and who were obese, had high body surface area, and those who drink >14 units of alcohol, 
were at higher risk of HF incidence. However, in women T2DM, hypercholesterolemia, >3 h/day of TV and sleep 
<7 h/day, low level of physical activity and high level of TV viewing were more strongly associated with HF 
incidence compared with men.  
CONCLUSION – Several modifiable risk factors (in particular diabetes) appear more strongly associated with 
HF in women compared with men. The relevance of these findings to HF characteristics and future outcomes, 
needs to be established. 
Keywords – heart failure, lifestyle, obesity, physical activity, diet 
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What is already known about this subject? 
It is already known that traditional risk factors including hypertension, smoking, obesity, as well as emerging risk 
factors including grip strength, cardiorespiratory fitness and physical activity levels are associated with heart 
failure incidence. It is also known that there are differences between the sexes in established heart failure. 
However, whether traditional or emerging risk factors differ by sex has not been investigated.  
What does this study add? 
We have demonstrated that several risk factors, including diabetes (T1DM & T2DM), high cholesterol, high TV 
viewing, low physical activity and those sleeping less than 7 hours per night, were associated with a higher hazard 
ratio for HF incidence and mortality in women compared to men. 
How might this impact on clinical practice? 
The early identification of women at risk of HF could be mediated by focusing on emerging modifiable risk 
factors including physical activity, sleep duration and TV-viewing alongside traditional risk factors including 
T1DM & T2DM, hypertension, hypercholesterolemia, smoking and alcohol consumption. These emerging risk 
factors could be a useful clinical measurement used in conjunction with traditional methods to more specifically 
risk stratify patients in the clinical setting.  
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INTRODUCTION  
Cardiovascular disease (CVD) is the leading cause of death worldwide. Over the last three decades there has been 
a decline in most CVDs, due to improvements in treatment. However, simultaneously, there has been an increase 
in the prevalence of heart failure (HF) in the UK and across Europe [1,2]. Within the UK, HF affects approximately 
900 000 people and has a poor prognosis, with a 17% mortality rate within the first year of diagnosis [3]. Although 
there has been progress in the management of HF, the social and economic burden to both patients and the health 
service remains high, accounting for ~2% of total NHS expenditure [4]. In Europe, as well as the UK, HF accounts 
for 1-2% of all hospital admissions, with the trend increasing over recent years [5]. With an aging population the 
prevalence of HF is projected to increase, [1,6] thus prevention at a population level is key to improving outcomes. 
To help direct specific interventions for HF, a clear understanding of modifiable risk factors is important. It has 
been shown, for example, that hypertension, smoking, obesity, grip strength, cardiorespiratory fitness, physical 
activity levels, alcohol intake and diet quality are associated with heart failure incidence [7–9]. However, whether 
these risk factors differ by sex has not been investigated. This is despite the fact that differences between the sexes 
in established heart failure have been previously reported [10]. Women who are older, have a higher BMI and 
have hypertension or diabetes are more likely to develop HF compared with men. Women are also more likely to 
develop HF with a preserved Ejection Fraction (HFpEF), with men being more likely to have a reduced ejection 
fraction (HFrEF) [11], and thus poorer outcomes.  
What is less well known however, is the effect that modifiable risk factors have on the risk of developing heart 
failure between the sexes. Previous work using data from the PREVEND study, a Dutch study investigating the 
effects of albuminuria on cardiovascular and renal disease, demonstrated that HF did occur earlier in men, that 
women were more likely to develop HFpEF later in life, and that atrial fibrillation, anti-hypertensive therapy and 
urinary-albumin excretion were the only sex specific risk factors associated with an increased risk of HF in women 
[11]. However, the study only looked at three modifiable risk factors – BMI, smoking habits and alcohol 
consumption, in a cohort of ~8500 participants. 
The aim of this study, therefore, is to investigate potential sex differences in the association of modifiable and 
traditional risk factors with heart failure incidence and mortality using data from the UK Biobank, a large 
population-based cohort study. 
 
METHODS 
Ethical Approval  
The UK Biobank study was approved by the North West Multi-Centre Research Ethics Committee (REC 
reference: 11/NW/03820) and all participants provided written informed consent to participate in the UK Biobank 
study. The study protocol is available online (http://www.ukbiobank.ac.uk/). 
Study design 
Between April 1st 2007 and December 31st 2010, UK Biobank recruited 502 536 participants (5.5% response rate), 
aged between 40-69 years from the general population [12]. We included a total of 468 941 participants in this 
current study, excluding those with self-reported or hospital admission diagnosis of cardiovascular disease (CVD) 
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(heart failure (HF), atrial fibrillations (AF), ischemic heart disease including myocardial infarction (MI) or stroke) 
at baseline (n=33 595). Participants attended one of 22 assessment centres across England, Wales and Scotland 
[13,14] where they completed a touch-screen questionnaire, and had physical measurements taken and provided 
biological samples. In this prospective, population-based study HF incidence and mortality (HF fatal and non-
fatal) events, in females and males were the measured outcomes. Analyses were adjusted for sociodemographic 
factors (age, ethnicity, deprivation index, month of assessment), lifestyle factors (dietary intake of major food 
groups, physical activity, sleeping, TV viewing and smoking) and obesity-related traits (height, weight, body mass 
index (BMI)).  
Procedures 
Date of death was obtained from death certificates held by the National Health Service (NHS) Information Centre 
(England and Wales) and the NHS Central Register Scotland (Scotland). Date and reason of hospital admissions 
were identified via record linkage to Health Episode Statistics (HES) (England and Wales) and to the Scottish 
Morbidity Records (SMR01) (Scotland). Detailed information regarding the linkage procedure can be found at 
http://www.ic.nhs.uk/services/medical-research-information-service. At the time of analysis, mortality data 
were available up to 31 January 2016. Mortality analysis was therefore censored at these dates or date of death if 
this occurred earlier. Hospital admission data were available until 31 March 2015, resulting in disease specific 
analyses being censored at this date, or the date of hospital admission or death if these occurred earlier. Incident 
heart failure was defined as a hospital admission or death with ICD10 code I50.0, I50.2, I50.9 [15]. 
Details of the procedures used to obtain all medical, socio-economic and anthropometric measurements can be 
found in the UK Biobank online protocol (http://www.ukbiobank.ac.uk). 
Statistical analysis  
Sex-specific associations of predictors on HF incidence and mortality were studied using Cox-proportional hazard 
models for both females and males independently. Hazard ratios (HR) were used to determine the effect sizes. 
Women-to-men HR ratios were then estimated using Cox models with sex: risk factor interaction terms. This term 
represents the statistical interaction between sex and the predictor and can be interpreted as the ratio of HR 
between female and male. Continuous predictors were categorised by quartiles to avoid assuming linear 
associations. Predictors with sex differences due to physiology (aerobic fitness, grip strength, and body surface 
area) were categorised within each sex; other predictors (socio-economic status, physical activity, and blood/pulse 
pressure) were categorised using the overall sample. Dietary intake and TV viewing were categorised using overall 
tertiles instead of quartiles because of tied values.  
A comprehensive list of covariates was fitted into the models: age, ethnicity, deprivation index, height, medication 
for CVD, and prevalent comorbidity (any cancers, depression, anxiety, schizophrenia, substance and alcohol 
problems, chronic obstructive pulmonary disease, chronic live disease, inflammatory bowel disease, and chronic 
fatigue syndrome) at recruitment. These factors were regarded as potential confounders based on the causal 
assumptions presented in a directed acyclic graph (Supplementary Figure 1). A sensitivity analysis was conducted 
to exclude any participants with HF events in the first two years of follow-up (Supplementary Table 2). Complete 
case analysis was used in handling missing data. All analyses were conducted in R version 3.5.1 with the package 
survival.  
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RESULTS 
Of the 502 536 participants recruited to UK Biobank, 468 941 (96%) participants were included in the current 
study, after excluding participants with CVD at baseline (n=33 595). The mean follow-up period was 9.0 years 
[range 7.4–11.9] for HF mortality and 8.2 [range 6.5–13.0] years for incidence. During the follow-up 1812 
participants had a HF event, in which 763 were fatal. Among the 262 325 women, 651 had HF events where 221 
were fatal. The incidence rate for women and men were 3.53 and 8.00 per 10,000 person-years. The hazard for 
HF incidence and mortality in women was 0.45 ([95% CI: 0.41–0.49], p<0.0001) and 0.33 ([0.28; 0.38], p<0.0001) 
compared to men. 
The characteristics of participants by sex are presented in Table 1. Compared to men, women had lower levels of 
physical activity, fitness and grip strength. A higher proportion of healthy lifestyle factors were observed in 
women, including non-smokers, lower intake of red and processed meat and higher intake of fruit and vegetables. 
However, a higher proportion of women reported consuming more than >14 units of alcohol per week.  
 
Table 1. Cohort characteristics 
  Female (n=262 325) Male (n=206 600) 
  
Data 
availabled n (%) / mean (SD) 
Data 
availabled n (%) / mean (SD) 
Mean (SD) age (years) 262 325 56.1 (7.99) 206 600 56.2 (8.21) 
Ethnicity 261 100  205 225  
White  247 041 (94.6)  193 898 (94.5) 
Mixed  1 800 (0.7)  1 035 (0.5) 
South Asian  4 372 (1.7)  4 666 (2.3) 
Black   4 417 (1.7)  3 245 (1.6) 
Chinese   997 (0.4)  559 (0.3) 
Other  2 493 (1.0)  1 822 (0.9) 
Mean (SD) height (m) 260 994 1.63 (0.06) 205 294 1.76 (0.07) 
Any medications for CVD 259 895 54 011 (20.8) 204 627 55 417 (27.1) 
Any prevalent comorbidities  260 979 51 034 (19.6) 205 688 28 727 (14.0) 
Deprivation 262 011   206 331   
Lowest   65 182 (24.9)  51 922 (25.2) 
Middle/Low   65 922 (25.2)  51 152 (24.8) 
Middle/High   66 449 (25.4)  50 675 (24.6) 
Highest   64 458 (24.6)   52 582 (25.5) 
Mean (SD) physical activity 
(MET.mins/week) 193 496 2549.7 (2358.3) 167 905 2799.5 (2657.5) 
Mean (SD) aerobic fitness 
(METs) 35 258 8.46 (2.2) 29 106 10.7 (2.4) 
Mean (SD) grip strength 261 169 23.4 (6.2) 205 539 39.6 (8.8) 
Mean (SD) systolic blood 
pressure (mmHg) 246 589 135.16 (19.2) 194 393 141.1 (17.3) 
Mean (SD) diastolic blood 
pressure (mmHg) 238 350 80.7 (9.9) 188 461 84.4 (9.8) 
Mean (SD) pulse pressure 
(mmHg) 238 349 54.4 (14.1) 188 461 56.6 (12.5) 
BMI categoriesa 260 995   205 294   
Underweight   2023 (0.8)  510 (0.2) 
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Normal   103 204 (39.5)  53 041 (25.8) 
Overweight   95 749 (36.7)  102 008 (49.7) 
Obese   60 019 (23.0)   49 735 (24.2) 
Central obesityb 261 261 78 991 (30.2) 205 559 142 851 (69.5) 
Waist-height ratio > 0.5 260 932 143 642 (55.0) 205 256 161 014 (78.4) 
Mean (SD) body surface area 
(m2) 260 994 1.79 (0.18) 205 294 2.04 (0.19) 
Mean (SD) hours of watching 
television a day 258 211 2.75 (1.5) 202 006 2.76 (1.5) 
Sleep duration 259 963   205 174   
Short sleeper (< 7 h/day)   62 373 (24.0)  51 466 (25.1) 
Normal (7-9 h/day)   192 939 (74.2)  150 514 (73.4) 
Long sleeper (> 9 h/day)   4651 (1.8)   3194 (1.6) 
Smoking 260 906   205345   
Never   156 584 (60.0)  103 661 (50.5) 
Former   81 265 (31.1)  76 013 (37.0) 
Current   23 057 (8.8)   25 671 (12.5) 
Weekly alcohol intake <14 units 236 273 174 837 (74.0) 191 079 78276 (41.0) 
Mean (SD) frequency of 
processed meat intake a week 261 273 1.58 (1.00) 205 583 2.20 (1.06) 
Mean (SD) frequency of oily fish 
intake a week 260 558 1.66 (0.92) 204 608 1.59 (0.94) 
Mean (SD) portion of red meat 
intake  262 325 1.97 (1.3) 206 600 2.26 (1.5) 
Mean (SD) portion of fruit and 
vegetable intake 262 325 4.38 (2.3) 206 600 3.76 (2.4) 
Prevalent conditions at 
recruitmentc         
Type 1 diabetes 262 223 543 (0.2) 206 448 822 (0.4) 
Type 2 diabetes 262 223 7548 (2.9) 206 448 11 020 (5.3) 
Hypertension 262 325 58 034 (22.1) 206 600 57 058 (27.6) 
High cholesterol  259 895 27 321 (10.5) 204 627 34 642 (16.9) 
a Underweight: BMI < 18.5; Normal: 18.5–<25; Overweight: 25–<30; Obese: ≥30 
b Central obesity: waist-hip ratio >85 cm for female and >90 cm for male 
c Prevalent conditions at recruitments were self-reported clinician diagnosis 
d Participants with data available out of 273,391 females and 229,129 males recruited in UK Biobank.   
 
Obesity-related risk factors and HF risk 
The HR for the association of HF (incidence) with adiposity are presented in Figures 1 and Figure 2 for men and 
women, respectively. Results for HF mortality are presented in supplementary Table S1. BMI, central obesity, 
waist-to-height ratio, body fat % and body surface area (BSA) were associated with a higher risk of HF incidence 
in both women and men, after adjustment for age, sex, ethnicity, height, medication for CVD and prevalent 
morbidities at recruitment (Figures 1 and 2). A higher risk for HF incidence and mortality was observed for 
underweight, obese, central obese and in those with high waist-to-height ratio in both men and women. When the 
risk of obesity for HF incidence and mortality by sex was compared, there were no evidence of any significant 
difference between men and women (Table 2).  
Existing conditions at recruitment   
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Type 1 (T1DM) and type 2 diabetes (T2DM), hypertension, and hypercholesterolemia were associated with HF 
incidence (Figures 1 and 2) and mortality regardless of sex (Supplementary Table S1). However, the association 
of T2DM and hypercholesterolemia were stronger in female than in male, the ratios of HR ranged from 32% to 
92% (Table 2).  
 
Table 2. Women-to-men HR ratio on HF incidence and mortality 
  Incident heart failure Heart failure mortality 
  
W:M HR Ratio 
(95% CI) P 
W:M HR Ratio 
(95% CI) P 
Prevalent conditionsa         
Type 1 diabetes 1.68 (0.77, 3.68) 0.19 1.98 (0.62, 6.31) 0.25 
Type 2 diabetes 1.73 (1.34, 2.24) < 0.0001 1.92 (1.25, 2.94) 0.003 
Hypertension 1.18 (0.97, 1.44) 0.09 1.21 (0.88, 1.66) 0.24 
High cholesterol  1.32 (1.06, 1.63) 0.01 1.46 (1.03, 2.07) 0.03 
Deprivation         
Low 0.90 (0.68, 1.19) 0.45 0.70 (0.44, 1.10) 0.12 
Lower-middle 0.80 (0.60, 1.08) 0.14 0.69 (0.43, 1.12) 0.14 
Upper-middle 0.79 (0.57, 1.08) 0.13 0.65 (0.39, 1.10) 0.11 
High 1 (Reference)   1 (Reference)   
Total PA MET.min/week         
≤802 1.43 (1.02, 2.00) 0.04 2.49 (1.41, 4.41) 0.002 
>802 to 1737 1.21 (0.84, 1.74) 0.30 1.48 (0.78, 2.81) 0.23 
>1737 to 3386 1.22 (0.84, 1.77) 0.30 1.64 (0.87, 3.11) 0.13 
>3386  1 (Reference) - 1 (Reference) - 
Aerobic fitness (MET)         
Lowest  0.59 (0.17, 1.96) 0.39 1.65 (0.17, 15.85) 0.66 
Middle/Low 0.89 (0.24, 3.24) 0.86 2.37 (0.22, 26.06) 0.48 
Middle/High 0.68 (0.13, 3.46) 0.64 0.00 (0.00, Inf) 1.00 
Highest 1 (Reference) - - - 
Grip strength (Kg)         
Lowest  0.92 (0.66, 1.29) 0.65 0.99 (0.56, 1.78) 0.98 
Middle/Low 1.25 (0.87, 1.79) 0.23 1.39 (0.76, 2.55) 0.29 
Middle/High 1.08 (0.74, 1.59) 0.68 0.95 (0.49, 1.83) 0.87 
Highest 1 (Reference) - 1 (Reference) - 
Systolic blood pressure (mmHg)         
≤125 1 (Reference) - 1 (Reference) - 
>125 to 138 1.34 (0.94, 1.93) 0.11 0.92 (0.52, 1.63) 0.77 
>138 to 152 1.31 (0.94, 1.83) 0.11 0.97 (0.57, 1.64) 0.91 
>152 1.28 (0.92, 1.76) 0.14 1.03 (0.62, 1.71) 0.92 
Diastolic blood pressure (mmHg)          
≤75 1 (Reference) - 1 (Reference) - 
>75 to 82 1.05 (0.78, 1.43) 0.74 0.87 (0.54, 1.40) 0.56 
>82 to 89 1.27 (0.95, 1.69) 0.11 0.81 (0.51, 1.29) 0.37 
>89 1.31 (0.98, 1.75) 0.07 1.07 (0.66, 1.72) 0.79 
Pulse pressure (beats/min)         
≤47 1 (Reference) - 1 (Reference) - 
>47 to 55 1.20 (0.83, 1.72) 0.34 1.03 (0.58, 1.83) 0.93 
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>55 to 66 1.18 (0.84, 1.65) 0.33 0.93 (0.54, 1.59) 0.79 
>66 1.16 (0.86, 1.57) 0.33 1.03 (0.63, 1.67) 0.92 
BMI categories b         
Underweight 0.62 (0.23, 1.66) 0.34 0.68 (0.17, 2.62) 0.57 
Normal 1 (Reference) - 1 (Reference) - 
Overweight 0.95 (0.72, 1.26) 0.71 0.82 (0.53, 1.27) 0.37 
Obese 1.17 (0.90, 1.53) 0.23 1.28 (0.85, 1.92) 0.24 
Body surface area categories         
Lowest  1 (Reference) - 1 (Reference) - 
Middle/Low 0.91 (0.66, 1.25) 0.55 0.71 (0.43, 1.16) 0.17 
Middle/High 0.94 (0.69, 1.28) 0.69 0.67 (0.41, 1.08) 0.1 
Highest 1.00 (0.76, 1.31) 0.99 0.85 (0.56, 1.30) 0.46 
Central obesity c 0.91 (0.72, 1.16) 0.46 0.89 (0.62, 1.30) 0.56 
Waist-height ratio > 0.5 0.91 (0.69, 1.20) 0.51 0.90 (0.59, 1.38) 0.63 
TV viewing          
≤ 1 h/day 1 (Reference) - 1 (Reference) - 
> 1 to 3 h/day 1.48 (1.11, 1.97) 0.007 1.38 (0.84, 2.25) 0.2 
> 3 h/day  1.59 (1.25, 2.02) 0.0001 2.09 (1.41, 3.09) 0.0003 
Sleep duration         
Short sleeper (< 7 h/day) 1.13 (0.91, 1.41) 0.27 1.02 (0.72, 1.46) 0.89 
Normal (7-9 h/day) 1 (Reference) - 1 (Reference) - 
Long sleeper (> 9 h/day) 0.84 (0.53, 1.35) 0.48 0.81 (0.36, 1.85) 0.62 
Smoking         
Never 1 (Reference) - 1 (Reference) - 
Former 0.95 (0.76, 1.19) 0.68 1.18 (0.82, 1.70) 0.36 
Current 0.91 (0.69, 1.21) 0.53 0.94 (0.61, 1.44) 0.76 
Weekly alcohol intake <14 units 0.98 (0.77, 1.25) 0.87 1.01 (0.68, 1.49) 0.97 
Processed meat intake         
Never or less than once a week 1 (Reference) - 1 (Reference) - 
Once a week 0.88 (0.69, 1.14) 0.34 0.88 (0.59, 1.33) 0.56 
More than once a week 0.82 (0.64, 1.06) 0.13 0.75 (0.50, 1.13) 0.16 
Oily fish intake         
Never or less than once a week 0.96 (0.73, 1.25) 0.75 0.95 (0.62, 1.48) 0.84 
Once a week 0.92 (0.70, 1.20) 0.53 0.99 (0.63, 1.54) 0.96 
More than once a week 1 (Reference) - 1 (Reference) - 
Red meat intake          
≤ 1.5 portions/week 1 (Reference) - 1 (Reference) - 
> 1.5 to 2 portions/week 1.06 (0.79, 1.40) 0.71 0.97 (0.60, 1.57) 0.89 
> 2 portions/week 0.92 (0.74, 1.15) 0.47 0.91 (0.64, 1.29) 0.61 
Fruit and vegetable intake        
≤ 3 portions/week 0.90 (0.71, 1.14) 0.4 0.95 (0.65, 1.39) 0.78 
> 3 to 4.7 portions/week 0.93 (0.72, 1.20) 0.57 1.00 (0.66, 1.51) 1 
> 4.7 portions/week 1 (Reference) - 1 (Reference) - 
 
Data presented are HR with 95% CI. Analyses adjusted for age, ethnicity, deprivation index, month of assessment, 
height, medication for CVD (except for prevalent conditions at recruitment), prevalent comorbidity at recruitment.  
a Prevalent condition at recruitments were self-reported clinician diagnosis 
b Underweight: BMI < 18.5; Normal: 18.5–<25; Overweight: 25–<30; Obese: ≥30 
c Central obesity: waist-hip ratio >85 cm for female and 90 cm for male 
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Lifestyle factors and HF risk 
For physical activity, fitness and grip strength, HF incidence and mortality were higher for those individuals in 
the lowest quartile (the most inactive, unfit and the lowest strength) compared to the reference category (the 
highest quartile) for women and men (Figures 1 and 2), respectively, as expected. However, the association 
between physical activity and HF mortality in men, was not significant (Supplementary Table 1).  
Higher levels of TV-viewing had a more deleterious association with risk in women compared to men (Table 2). 
The risk associated with being a smoker was higher for HF mortality than HF incidence, for women and men, 
respectively. For sleep duration, being a short sleeper (<7 h/day) and long sleeper (>9 h/day) were associated with 
a higher risk of HF incidence compared to a normal sleeper (7-9 h/day). The association between HF outcomes 
and alcohol consumption showed that men and women who reported a weekly intake ≤14 units of alcohol had a 
lower risk of HF incidence and mortality, with similar risk between women and men. There was evidence of 
excess risk of HF incidence and mortality in women compared to men for those reporting high levels of TV-
viewing (>3 h/day) and low levels of physical activity (Table 2). A two-year landmark analysis has shown 
consistent results as the main analysis.  
 
DISCUSSION  
The current study has demonstrated that a wide range of physical and lifestyle factors are associated with HF 
incidence and mortality, and generally these associations do not differ by sex, except for some modifiable life-
style factors which carry higher risk in woman compared with men. This means that screening for HF risk and 
intervention in those at high risk can be uniform between men and women, although vigilance may be warranted 
in women who have diabetes, high cholesterol, low physical activity and high sedentary behaviours, as these were 
stronger risk factors in women. Several studies have demonstrated the association of physical and lifestyle factors 
with HF incidence and mortality, and the current findings are in broad agreement with these [7]. Meyer et al 
conducted a sub-analysis of the participants in the PREVEND study, looking at incidence and epidemiology of 
new onset HF in ~8500 middle-aged adults [11]. Similar to our analysis, they concluded that obesity, hypertension, 
previous MI, atrial fibrillation, diabetes mellitus, and hypercholesterolemia were significantly associated with new 
onset HF in both genders. Their analysis differed thereafter, as they looked at HF with and without preserved 
ejection fraction as the outcomes. They analysed biomarkers as novel risk factors, in contrast to the novel physical 
risk factors we analysed. They concluded, as has previously been published, that women were more likely to 
develop HF with HFpEF, which may be due to differing underlying pathophysiology from those with HFrEF; 
which we are unable to comment on in this current study.  
When looking at associations with dietary intake it has been shown that a higher diet score based on intake of 
fruits, vegetables, whole grains, fish, nuts/seeds, red and processed meats, sugar-sweetened beverages, trans fat, 
sodium and the polyunsaturated to saturated fat ratio, was associated with lower HF incidence [9]. The same 
authors also investigated associations of Dietary Approaches to Stop Hypertension (DASH), Alternative Healthy 
Eating Index (AHEI) and American Heart Association (AHA) 2020 dietary goals diet scores with HF incidence 
with similar findings. Furthermore, Pandey and colleagues have demonstrated a linear, dose-response negative 
association between physical activity levels and HF incidence [16]. Similarly, it has been previously shown that 
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cardiorespiratory fitness and grip strength have an inverse relationship with HF incidence [8,17]. Sedentary 
behaviours, such as time spent watching TV, have previously been found to be associated with CVD mortality, 
independently of physical activity levels [18–20] and Young et al have extended these findings to show that high 
sedentary time was associated with increased risk of HR incidence in males only [21]. The current paper agrees 
with these, and extends them, to also look at HF mortality and importantly to investigate whether the associations 
are consistent between men and women. A recent study investigating risk of myocardial infarction found higher 
HR for systolic blood pressure, hypertension, and smoking status/intensity in women compared to men, [22] 
highlighting sex differences in associations with other CVDs. Furthermore, previous work has indicated that 
women with a higher BMI and who have hypertension or diabetes are more likely to develop HF than men [10]. 
We have shown that for the majority of factors there was little difference in the HR for either HF incidence or 
mortality between men and women. We did, however, find that in women with diabetes, high cholesterol, high 
TV viewing, and low physical activity were associated with a higher hazard ratio for HF incidence and mortality 
compared to men. This may indicate that increasing physical activity, and improving sleep and reducing sedentary 
behaviours may offer more benefit in women compared to men to lower their HF risks. Further work is clearly 
needed to confirm these associations. It is also notable that others have shown sex differences in the associations 
of T2DM with CVD in general [23] with emerging evidence for T1DM [24], lending external validity to our 
findings. With respect to cholesterol, we have previously shown that statins lower HF risk in a meta-analysis of 
randomised trials [25] and it may be women, who receive less statins generally, are exposed to greater HF risk as 
a result of this. However, this remains speculative and requires formal examination.  
UK Biobank aimed to be representative of the general population in terms of age, sex, ethnicity and socioeconomic 
status but is unrepresentative in terms of lifestyle, with participants less likely to be obese and have lower disease 
frequency – indicative of a “healthy volunteer” selection bias [26]. Therefore, caution should be heeded in 
generalizing summary statistics to the general population. Our study benefited from a very large number of 
participants, recruited from the general population, across the whole of the UK, which allowed us to investigate 
sex differences in the current analyses. Reverse causality is possible in any observational study; and whilst our 
results were similar after a landmark analysis of events occurring from 2 years after recruitment, we cannot 
exclude the potential of reverse causality in the current study. We also acknowledge we do not have information 
on different types of HF, including HFpEF or HFrEF, which would have been informative. It should be noted that 
there are multiple tests conducted in this study, and the number of false positives may be disproportionally inflated. 
On the other hand, given the relatively small number of events, some of analysis may be underpowered and 
resulting in the lack of statistical significance. 
In conclusion the current study has demonstrated that a broad range of physical and lifestyle factors are associated 
with HF incidence and mortality. We have extended previous work by demonstrating that whilst the risk was 
broadly similar between men and women, diabetes, high cholesterol, physical activity, TV viewing and sleep 
show significant differences in HF risk between the sexes. The early identification of women at risk of HF could 
be mediated by focusing on these modifiable lifestyle risk factors in particular. They may be useful measurements 
used in conjunction with traditional methods to more specifically risk stratify patients in the clinical setting. The 
relevance of these findings to differentiate HF characteristics by sex and future outcomes, needs further 
established. 
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Figure legends  
 
Figure 1. Risk factors for heart failure incidence in women 
Data presented as hazard ratio and their 95% CI. Adjusted for age, ethnicity, deprivation index, month of 
assessment, height, medication for CVD (except for prevalent conditions at recruitment), prevalent comorbidity 
score at recruitment.  
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Figure 2. Risk factors for heart failure incidence in men 
Data presented as hazard ratio and their 95% CI. Adjusted for age, ethnicity, deprivation index, month of 
assessment, height, medication for CVD (except for prevalent conditions at recruitment), prevalent comorbidity 
score at recruitment. *Fitness has insufficient number of events to perform the analyses for mortality in women.  
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Figure 3. Women-to-men HR ratio on heart failure incidence.  
Data presented as ratio of the hazard ratio of women-to-men, and their 95% CI. Adjusted for age, ethnicity, 
deprivation index, month of assessment, height, medication for CVD (except for prevalent conditions at 
recruitment), prevalent comorbidity score at recruitment. I hazard ratio above 1 suggest a higher risk in women 
compare to men, whereas a hazard ratio below 1 suggest a higher risk in men compare to women.  
 
